Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, T-Type | 10 | 2019 | 29 | 3.380 |
Why?
|
| Ethanol | 12 | 2023 | 189 | 2.840 |
Why?
|
| Geniculate Bodies | 20 | 2006 | 22 | 2.450 |
Why?
|
| Thalamus | 8 | 2010 | 32 | 2.100 |
Why?
|
| Neurons | 15 | 2017 | 407 | 1.990 |
Why?
|
| Alcohol Withdrawal Seizures | 3 | 2023 | 3 | 1.970 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2023 | 59 | 1.910 |
Why?
|
| Alcoholism | 5 | 2023 | 101 | 1.770 |
Why?
|
| Neural Pathways | 9 | 2018 | 94 | 1.740 |
Why?
|
| Receptors, Metabotropic Glutamate | 7 | 2013 | 24 | 1.530 |
Why?
|
| Magnetoencephalography | 5 | 2021 | 14 | 1.500 |
Why?
|
| Seizures | 4 | 2023 | 64 | 1.450 |
Why?
|
| Ethosuximide | 3 | 2015 | 3 | 1.400 |
Why?
|
| Calcium Channel Blockers | 4 | 2019 | 48 | 1.360 |
Why?
|
| Animals | 48 | 2023 | 7510 | 1.360 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2019 | 26 | 1.280 |
Why?
|
| Cerebral Cortex | 5 | 2012 | 124 | 1.130 |
Why?
|
| Nerve Net | 4 | 2021 | 123 | 1.120 |
Why?
|
| Central Nervous System Depressants | 6 | 2021 | 63 | 1.070 |
Why?
|
| Brain | 5 | 2021 | 948 | 1.050 |
Why?
|
| Mice | 15 | 2023 | 2474 | 1.040 |
Why?
|
| Electroencephalography | 4 | 2017 | 72 | 1.010 |
Why?
|
| Nitric Oxide | 7 | 2006 | 111 | 0.950 |
Why?
|
| Brain Mapping | 5 | 2018 | 178 | 0.910 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2022 | 47 | 0.900 |
Why?
|
| Nitric Oxide Synthase | 6 | 2009 | 35 | 0.860 |
Why?
|
| Pentylenetetrazole | 3 | 2019 | 4 | 0.840 |
Why?
|
| Action Potentials | 7 | 2019 | 177 | 0.820 |
Why?
|
| Status Epilepticus | 2 | 2013 | 18 | 0.780 |
Why?
|
| Brain Concussion | 2 | 2022 | 64 | 0.730 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 16 | 0.680 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 2 | 2012 | 8 | 0.670 |
Why?
|
| Visual Pathways | 7 | 2002 | 32 | 0.670 |
Why?
|
| Glutamic Acid | 3 | 2012 | 47 | 0.660 |
Why?
|
| Synapses | 6 | 2009 | 83 | 0.650 |
Why?
|
| Benzamides | 1 | 2018 | 50 | 0.630 |
Why?
|
| Piperidines | 1 | 2018 | 118 | 0.590 |
Why?
|
| Feedback | 3 | 2006 | 43 | 0.560 |
Why?
|
| Rest | 1 | 2017 | 53 | 0.560 |
Why?
|
| Ferrets | 6 | 2006 | 20 | 0.540 |
Why?
|
| Optical Fibers | 2 | 2014 | 5 | 0.510 |
Why?
|
| Intralaminar Thalamic Nuclei | 3 | 2005 | 3 | 0.480 |
Why?
|
| Male | 20 | 2019 | 19202 | 0.480 |
Why?
|
| Wakefulness | 1 | 2014 | 25 | 0.460 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 6 | 0.460 |
Why?
|
| Pilocarpine | 1 | 2013 | 5 | 0.460 |
Why?
|
| Movement | 1 | 2014 | 50 | 0.450 |
Why?
|
| Electromyography | 1 | 2013 | 59 | 0.450 |
Why?
|
| Protein Kinase C | 1 | 2013 | 31 | 0.430 |
Why?
|
| Sleep Stages | 1 | 2012 | 6 | 0.430 |
Why?
|
| Channelopathies | 2 | 2010 | 3 | 0.420 |
Why?
|
| Neuronal Plasticity | 2 | 2010 | 80 | 0.410 |
Why?
|
| Brain Stem | 3 | 2009 | 20 | 0.400 |
Why?
|
| Receptors, Serotonin | 1 | 2012 | 7 | 0.400 |
Why?
|
| Mice, Inbred DBA | 3 | 2018 | 39 | 0.400 |
Why?
|
| Anticonvulsants | 4 | 2019 | 65 | 0.390 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 881 | 0.390 |
Why?
|
| Gene Expression | 3 | 2010 | 337 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 764 | 0.380 |
Why?
|
| Biological Clocks | 1 | 2010 | 4 | 0.380 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2010 | 3 | 0.380 |
Why?
|
| Ion Channels | 1 | 2010 | 24 | 0.360 |
Why?
|
| Luminescent Proteins | 2 | 2021 | 26 | 0.350 |
Why?
|
| Stress, Psychological | 1 | 2012 | 222 | 0.350 |
Why?
|
| Visual Cortex | 3 | 2005 | 34 | 0.340 |
Why?
|
| Cats | 13 | 2003 | 108 | 0.340 |
Why?
|
| Electric Stimulation | 7 | 2009 | 104 | 0.330 |
Why?
|
| Models, Neurological | 3 | 2021 | 117 | 0.330 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 90 | 0.330 |
Why?
|
| Epilepsy | 1 | 2010 | 82 | 0.330 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 261 | 0.300 |
Why?
|
| Synaptic Transmission | 6 | 2006 | 116 | 0.290 |
Why?
|
| Animals, Newborn | 7 | 2006 | 112 | 0.280 |
Why?
|
| Epilepsy, Absence | 1 | 2006 | 1 | 0.280 |
Why?
|
| Patch-Clamp Techniques | 6 | 2009 | 75 | 0.270 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 43 | 0.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2006 | 32 | 0.260 |
Why?
|
| Glycine | 1 | 2005 | 27 | 0.250 |
Why?
|
| Neural Inhibition | 1 | 2005 | 27 | 0.250 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 36 | 0.240 |
Why?
|
| Amino Acids | 3 | 2013 | 46 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2021 | 38 | 0.230 |
Why?
|
| Evoked Potentials | 2 | 2021 | 17 | 0.230 |
Why?
|
| Photic Stimulation | 6 | 1999 | 158 | 0.230 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 534 | 0.230 |
Why?
|
| Penicillamine | 2 | 2006 | 2 | 0.220 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 493 | 0.220 |
Why?
|
| Random Allocation | 2 | 2014 | 227 | 0.220 |
Why?
|
| Sleep | 1 | 2003 | 92 | 0.210 |
Why?
|
| Neurofilament Proteins | 2 | 2000 | 13 | 0.210 |
Why?
|
| Nitrergic Neurons | 1 | 2002 | 1 | 0.210 |
Why?
|
| Body Patterning | 1 | 2002 | 3 | 0.200 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 65 | 0.200 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2003 | 75 | 0.200 |
Why?
|
| Calcium | 4 | 2019 | 306 | 0.200 |
Why?
|
| Drug Interactions | 3 | 2006 | 77 | 0.200 |
Why?
|
| Veterans | 1 | 2022 | 68 | 0.200 |
Why?
|
| Bicuculline | 3 | 1993 | 10 | 0.200 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2001 | 2 | 0.200 |
Why?
|
| Patient Discharge | 1 | 2023 | 186 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 629 | 0.190 |
Why?
|
| Neurotransmitter Agents | 2 | 2000 | 26 | 0.190 |
Why?
|
| Humans | 11 | 2023 | 32082 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2003 | 469 | 0.180 |
Why?
|
| Female | 7 | 2021 | 19999 | 0.180 |
Why?
|
| Interneurons | 6 | 2003 | 22 | 0.170 |
Why?
|
| Convulsants | 1 | 2019 | 3 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2021 | 156 | 0.170 |
Why?
|
| Tupaiidae | 2 | 1989 | 2 | 0.170 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 60 | 0.160 |
Why?
|
| Vision, Monocular | 1 | 1998 | 1 | 0.160 |
Why?
|
| Retina | 2 | 1996 | 61 | 0.160 |
Why?
|
| Sensory Deprivation | 1 | 1998 | 15 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1020 | 0.160 |
Why?
|
| Hospitalization | 1 | 2021 | 468 | 0.160 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 2 | 0.150 |
Why?
|
| Light | 1 | 1998 | 24 | 0.150 |
Why?
|
| Membranes, Artificial | 1 | 1998 | 7 | 0.150 |
Why?
|
| Microscopy, Electron | 4 | 2003 | 30 | 0.150 |
Why?
|
| Parvalbumins | 1 | 2017 | 7 | 0.150 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 26 | 0.150 |
Why?
|
| Glass | 2 | 1998 | 2 | 0.150 |
Why?
|
| Glutathione | 1 | 1998 | 43 | 0.150 |
Why?
|
| Dendrites | 4 | 2003 | 16 | 0.150 |
Why?
|
| Nitric Oxide Donors | 3 | 2006 | 8 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 62 | 0.150 |
Why?
|
| Macaca mulatta | 3 | 2012 | 305 | 0.150 |
Why?
|
| Iontophoresis | 2 | 1996 | 6 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 155 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2012 | 406 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2018 | 92 | 0.140 |
Why?
|
| Membrane Potentials | 3 | 2006 | 81 | 0.140 |
Why?
|
| Equipment Design | 2 | 2014 | 171 | 0.140 |
Why?
|
| Contrast Media | 1 | 2017 | 138 | 0.140 |
Why?
|
| Rats | 4 | 2006 | 1592 | 0.130 |
Why?
|
| Xanthenes | 2 | 2006 | 3 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 25 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 263 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 81 | 0.130 |
Why?
|
| Evoked Potentials, Visual | 2 | 2014 | 6 | 0.130 |
Why?
|
| Photolysis | 3 | 1999 | 4 | 0.120 |
Why?
|
| Macaca fascicularis | 2 | 2006 | 434 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2006 | 507 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 255 | 0.120 |
Why?
|
| Biophysics | 1 | 2014 | 11 | 0.120 |
Why?
|
| Mortality | 1 | 2015 | 125 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 41 | 0.120 |
Why?
|
| Tungsten | 1 | 1993 | 2 | 0.110 |
Why?
|
| Electrodes | 1 | 1993 | 17 | 0.110 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 126 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1993 | 43 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2013 | 142 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2013 | 57 | 0.110 |
Why?
|
| Acute Disease | 1 | 2013 | 252 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 2145 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 80 | 0.100 |
Why?
|
| Maternal Deprivation | 1 | 2012 | 3 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2013 | 249 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2013 | 547 | 0.100 |
Why?
|
| Electrophysiology | 4 | 1999 | 70 | 0.100 |
Why?
|
| Neoplasms | 1 | 2018 | 728 | 0.090 |
Why?
|
| Afferent Pathways | 3 | 2000 | 23 | 0.090 |
Why?
|
| Cell Size | 4 | 2003 | 38 | 0.090 |
Why?
|
| Adult | 3 | 2018 | 9375 | 0.090 |
Why?
|
| Thalamic Nuclei | 2 | 2001 | 3 | 0.090 |
Why?
|
| Olfactory Bulb | 1 | 2009 | 4 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 5 | 0.090 |
Why?
|
| NADPH Dehydrogenase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 90 | 0.080 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 26 | 0.080 |
Why?
|
| Nitroprusside | 2 | 1999 | 5 | 0.080 |
Why?
|
| Middle Aged | 3 | 2018 | 11834 | 0.080 |
Why?
|
| Pulvinar | 2 | 2003 | 2 | 0.070 |
Why?
|
| Glutamate Decarboxylase | 2 | 2003 | 17 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 15 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 12 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 18 | 0.070 |
Why?
|
| Cyclic GMP | 1 | 2006 | 13 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 17 | 0.070 |
Why?
|
| Triazoles | 1 | 2006 | 14 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2006 | 31 | 0.070 |
Why?
|
| Guanosine Diphosphate | 1 | 2006 | 2 | 0.070 |
Why?
|
| Thionucleotides | 1 | 2006 | 3 | 0.070 |
Why?
|
| Picrotoxin | 1 | 2006 | 3 | 0.070 |
Why?
|
| Gluconates | 1 | 2006 | 4 | 0.070 |
Why?
|
| Epilepsy, Generalized | 1 | 2006 | 4 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 42 | 0.070 |
Why?
|
| Visual Perception | 2 | 1999 | 116 | 0.070 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 33 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2006 | 38 | 0.070 |
Why?
|
| Receptors, Glutamate | 1 | 2005 | 6 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2006 | 96 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 39 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1542 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 164 | 0.060 |
Why?
|
| Axons | 2 | 2003 | 34 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2006 | 288 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 276 | 0.060 |
Why?
|
| Reaction Time | 1 | 2005 | 117 | 0.060 |
Why?
|
| Cyclopropanes | 1 | 2005 | 19 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 462 | 0.060 |
Why?
|
| Acetylcholine | 2 | 2000 | 48 | 0.050 |
Why?
|
| Afghan Campaign 2001- | 1 | 2022 | 14 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2001 | 8 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 76 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2021 | 164 | 0.050 |
Why?
|
| Critical Care | 1 | 2021 | 105 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2001 | 294 | 0.040 |
Why?
|
| Xenon | 1 | 1999 | 2 | 0.040 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 15 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 40 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 81 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 742 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 114 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 114 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1998 | 18 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 38 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1998 | 60 | 0.040 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1998 | 1 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1998 | 4 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 1998 | 22 | 0.040 |
Why?
|
| Solutions | 1 | 1998 | 36 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1998 | 18 | 0.040 |
Why?
|
| Reference Values | 1 | 1998 | 246 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 1325 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 28 | 0.040 |
Why?
|
| Nerve Endings | 1 | 1996 | 4 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 169 | 0.040 |
Why?
|
| Military Personnel | 1 | 2018 | 92 | 0.040 |
Why?
|
| Primates | 1 | 2017 | 108 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1996 | 60 | 0.040 |
Why?
|
| Cycloleucine | 1 | 1996 | 1 | 0.040 |
Why?
|
| Calcium Channels | 1 | 1997 | 57 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1996 | 13 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 261 | 0.030 |
Why?
|
| Self Administration | 1 | 2017 | 297 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 770 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 943 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 604 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2009 | 77 | 0.030 |
Why?
|
| ROC Curve | 1 | 1995 | 163 | 0.030 |
Why?
|
| Lateral Thalamic Nuclei | 2 | 2003 | 2 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 225 | 0.030 |
Why?
|
| Signal Transduction | 1 | 1996 | 680 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 103 | 0.030 |
Why?
|
| Visual Fields | 1 | 1992 | 27 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 55 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3304 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2665 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3505 | 0.020 |
Why?
|
| Sex Attractants | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, R-Type | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, N-Type | 1 | 2009 | 3 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2009 | 7 | 0.020 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2009 | 8 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 23 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 61 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2009 | 7 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 33 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 64 | 0.020 |
Why?
|
| Pons | 1 | 2000 | 6 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2000 | 7 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1997 | 13 | 0.010 |
Why?
|